JPM2023: Breakthroughs await, but so do roadblocks

Cell and gene therapies – big opportunities, big challenges

This is the area where I think this tension is the most obvious. Everyone agrees that cell and gene therapies are poised for an explosion, with far more drugs in the pipeline than are currently approved, and the FDA predicts it will clear 10 to 20 per year by 2025.